Tumor necrosis factor (TNF) has been determined as an endogenous mediator for endotoxin-induced tumor necrosis. This macrophage product has been biochemically characterized and its protein structure defined by molecular cloning of the TNF gene. Experiments with antibodies to TNF demonstrated that TNF acts as an effector molecule of activated cytotoxic macrophages involved in tumor destruction.
Introduction
The endotoxin-induced tumor necrosis phenomenon has been the subject of intensive clinical, biological, and biochemical research for many decades (1, 2). Numerous attempts have been undertaken to separate the beneficial tumor cytotoxic effects of endotoxin from the harmful pathophysiological endotoxic effects. Elucidation of the lipid A structure as the endotoxic principle of bacterial lipopolysaccharide (LPS) revealed the chemical structure responsible for the tumor necrosis eliciting activity (3, 4). However, due to the work of OLD et al. (5) , it became obvious that the LPS-induced tumor necrosis was not a direct effect of LPS or lipid A on the tumor mass but rather an indirect phenomenon. An endogenous mediator, termed tumor necrosis factor (TNF), was elicited as a second messenger by LPS injection of animals with an activated reticular endothelial system. Characterization of the producer cells for TNF, requirements for TNF production and molecular cloning of the TNF genes in different species made clear that activated macrophages are a source for TNF (6, 7). The recombinant form of the TNF molecule was found as a 17,000 D protein in the case of human TNF (8). The amino acid sequence of the human TNF showed about 80 % homology with murine TNF. In contrast to the human TNF, murine TNF contained one potential N-glycosylation site (9). The activity of TNF seemed not to be species-specific.
Besides the tumor necrotic activity in vivo of TNF, a rather selective tumor cytotoxic activity of TNF has been observed and used as a sensitive in vitro test system. With the availability of purified and/or recombinant TNF, a number of biological TNF activities have been determined. Even though TNF was characterized as the endogenous mediator of endotoxininduced tumor necrosis, it has not been possible to separate the beneficial tumor necrotic effect as a distinct quality from all the other endotoxic activities.
Materials and Methods

Mice
Male and female C3H/He mice, 6 to 10 weeks of age, were obtained from Charles River Wiga, Sulzfeld, F.R.G., and C3H/HeJ mice were purchased from Jackson Laboratories, Bar Harbor, ME, U.S.A.
Reagents
Recombinant human TNF was generously supplied by BASF, Ludwigshafen, F.R.G., and recombinant IFN-y (produced by Genetech, Inc.) by Boehringer Ingelheim. Mycobacterium bovis, strain BCG (Phipps substrain, TCM 1029, Trudeau Mycobacterial Collection, Saranac Lake, NY, U.S.A.), pyran copolymer (National Cancer Institute, Bethesda, MD, U.S.A.), Corynebacterium parvum (Wellcome Research Laboratories, Beckenham, England) and latex beads (1-um polystyrene beads, Dow Chemical Co., Midland, MI, U.S.A.) were injected intraperitoneal^ to activate macrophages.
Assays for TNF
TNF samples were cultured with 4 X 10 3 ( 3 H)TdR-prelabeled L929 tumor cells for 48 h in a culture volume of 0.2 ml. Cytotoxicity was estimated by measuring release of ( 3 H)TdR from tumor cells and expressed as % release of total incorporated counts. In another test system, TNF samples were cultured with 2 X 10 4 L929 tumor cells for 24 h in 0.2 ml cultures in the presence of actinomycin D (2 ug/ml), and viable cells were determined by staining with crystal violet.
Macrophage cytotoxicity assay
( 3 H)TdR-prelabeled tumor cells (6 X 10 3 L929 or 1023 fibrosarcoma cells) were cultured together with 1.2 X 10 5 peritoneal exudate cells in 0.2 ml cultures for 48 h. Cytotoxicity was estimated by measuring release of ( 3 H)TdR from tumor cells and expressed as % release of total incorporated counts.
Blood parameters
Plasma glucose levels were determined with a Gluco-Quant glucose kit, and plasma lactate levels were measured with a Monotest-Lactat kit (both from Boehringer, Mannheim, F.R.G.).
Results
TNF as a tumor cytotoxic effector molecule of activated macrophages
The mechanism of tumor cell destruction by activated macrophages is not well understood. Cell contact of macrophages with tumor cells seemed to be required, and no soluble cytotoxic activity was measurable in conventional macrophage cytotoxicity assays. However, when macrophages are activated they become extremely sensitive to lipid A stimulation (10). Therefore, we investigated the production of TNF by murine macrophages upon LPS exposure and compared the TNF-producing ability with the tumoricidal capacity of these macrophages. Release of TNF from macrophages upon LPS stimulation was only observed when the macrophages had been appropriately activated before. The activation correlated with the potential of the macrophages for tumor cytotoxicity (Table 1) . Thus, only tumor cytotoxic macrophages were able to secrete TNF into the medium as a response to LPS. This indicated a possible role of TNF in macrophage tumor destruction.
Rabbit antibodies directed against semipurified murine TNF have been generated and had good TNF-neutralizing activity (11). These antibodies were also capable of inhibiting macrophage tumor cytotoxicity (Table 2) , even though no soluble TNF was found in the supernatants of these cytotoxic macrophages in the absence of added LPS. Culture morphology demonstrated an even more striking inhibition of macrophage tumor cell destruction by the TNF antibodies. Cultures of activated macrophages and tumor cells showed a strong cytopathic effect, whereas in identical cultures a Adherent peritoneal exudate cells from mice treated as indicated in the footnote to Table 1 were used. Tumoricidal activity was determined as in Table 1 .
but in the presence of anti-TNF the tumor cell density was as high as in the presence of non-activated macrophages. These results not only suggested participation of TNF in macrophage tumor cytotoxicity, but they also implied that this had to occur in a short-range or even membrane-bound fashion.
TNF as mediator of endotoxin effects
With the availability of purified recombinant TNF, in vivo effects after application of relatively large quantities of this mediator could be studied. (Table 3) . However, this effect was not due to endotoxin contamination of the TNF preparation, since this temperature decrease was also observed in the endotoxin low-responder mouse strain. Changes of blood and plasma parameters that are typical for endotoxin were observed after TNF application (13, 14) . Hematocrit levels were significantly increased after 30 min, plasma lactate levels were also increased after 6 h, and plasma glucose levels decreased after 6 h. These data indicated that TNF mediated the pathophysiological effects of endotoxin. This observation is supported by the data of BEUTLER et al. (15) , which demonstrated that antibodies to cachectin (which is probably identical with TNF (16)) protected mice from the lethal effects of endotoxin. Table 4 demonstrates the increased TNF sensitivity of human HeLa cells and mouse L929 fibrosarcoma cells when pretreated with IFN-y. In addition, the production of TNF is enhanced by IFN-y (23). Taken together, these effects demonstrate an effective amplification mechanism for TNF function by IFN-y.
Intravenous injection of TNF (3-4 mg/kg) into endotoxin-sensitive C3H/ He or endotoxin low responder C3H/HeJ mice induced a dramatic impair-
TNF as immunomodulator
Besides
TNF itself was also able to regulate the sensitivity of tumor cells to the cytotoxic effect of TNF (Table 5 ). Higher concentrations of TNF were required to induce 50 % reduction in cell viability when the sensitive L929 cells had been exposed to TNF previously. Also, this protective effect was up to a certain concentration dose dependent. There were two likely explanations for these observations. One could be the selective killing of the most sensitive cells by the pretreatment, leaving the least sensitive cells behind. The second possibility is that TNF induces a protective state in the cells. A similar self-resistance-induction has already been described for lymphotoxin (24) . These observations indicate that the cytotoxic effect of TNF can be regulated by IFN-y and TNF. It remains to be tested whether other TNF activities such as prostaglandin-production, which can regulate immune functions, undergo similar regulation.
Discussion
Lipid A is the structure responsible for the beneficial and harmful biological properties of bacterial endotoxin (3). Macrophages are exquisite responder cells to lipid A and react even more strongly when they are in an activated stage (10). Therefore, the idea has developed that endotoxin may cause its pathophysiological effects through interaction with this cell type and eventually via macrophage-derived mediators such as TNF and ILL The array of functions of TNF and IL 1 seems to be very similar (with the exception of the effects of IL 1 on T cells). A number of endotoxic effects can be induced with pure preparations of IL 1 or TNF. A clear picture of the molecular mechanisms underlying the mediation of endotoxin effects will probably emerge from ongoing studies with these mediators.
